litlas
Log inCreate account

A. Keith Stewart

Active 1992–2025

157
Papers
34,696
Citations
102
h-index
153
i10-index

Citations

Citations per year for A. Keith Stewart1987: 1 citations1988: 1 citations1989: 1 citations1990: 1 citations1992: 4 citations1993: 7 citations1994: 13 citations1995: 9 citations1996: 7 citations1997: 8 citations1998: 10 citations1999: 17 citations2000: 24 citations2001: 29 citations2002: 33 citations2003: 61 citations2004: 57 citations2005: 87 citations2006: 91 citations2007: 137 citations2008: 152 citations2009: 191 citations2010: 187 citations2011: 290 citations2012: 301 citations2013: 416 citations2014: 414 citations2015: 342 citations2016: 389 citations2017: 359 citations2018: 356 citations2019: 1,082 citations2020: 1,234 citations2021: 1,198 citations2022: 1,065 citations2023: 732 citations2024: 1,194 citations2025: 463 citations2026: 16 citations1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,873 citing papers, 29.2% of this breakdownChina: 902 citing papers, 6.8% of this breakdownGermany: 827 citing papers, 6.2% of this breakdownUnited Kingdom: 766 citing papers, 5.8% of this breakdownItaly: 758 citing papers, 5.7% of this breakdownFrance: 616 citing papers, 4.6% of this breakdownSpain: 553 citing papers, 4.2% of this breakdownCanada: 540 citing papers, 4.1% of this breakdownNetherlands: 376 citing papers, 2.8% of this breakdownAustralia: 346 citing papers, 2.6% of this breakdownGreece: 286 citing papers, 2.2% of this breakdownJapan: 282 citing papers, 2.1% of this breakdown
0%29.2%Other 23.7%

Institutions

Fields

  • Medicine64.3%
  • Biochemistry, Genetics and Molecular Biology29%
  • Immunology and Microbiology3.3%
  • Neuroscience0.9%
  • Computer Science0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Other1.3%

Topics

  • Multiple Myeloma Research and Treatments13.7%
  • Protein Degradation and Inhibitors7.5%
  • CAR-T cell therapy research4.4%
  • Ubiquitin and proteasome pathways3.7%
  • Peptidase Inhibition and Analysis3.4%
  • Cancer Genomics and Diagnostics1.9%
  • Other65.4%

Coauthors

All papers

Open in search
  1. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

    Authors: Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D. Cohen, A. Keith Stewart, Parameswaran Hari, Myo Htut, Alexander M. Lesokhin, Abhinav Deol, Nikhil C. Munshi, Elizabeth O’Donnell, David Avigan, Indrajeet Singh, Enrique Zudaire, Tzu‐Min Yeh, Alicia J. Allred, Yunsi Olyslager, Arnob Banerjee, Carolyn C. Jackson, Jenna D Goldberg, Jordan M. Schecter, William Deraedt, Sen Hong Zhuang, Jeffrey R. Infante, Dong Geng, Xiaoling Wu, Marlene J. Carrasco-Alfonso, Muhammad Akram, Farah Hossain, Syed Rizvi, Frank Fan, Yi Lin, Thomas G. Martin, Sundar Jagannath - The Lancet 2021 cited by 1,664

  2. Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

    Authors: Thomas G. Martin, Saad Z. Usmani, Jesús G. Berdeja, Mounzer Agha, Adam D. Cohen, Parameswaran Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander M. Lesokhin, Nikhil C. Munshi, Elizabeth O’Donnell, A. Keith Stewart, Jordan M. Schecter, Jenna D. Goldberg, Carolyn C. Jackson, Tzu‐Min Yeh, Arnob Banerjee, Alicia J. Allred, Enrique Zudaire, William Deraedt, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Deepu Madduri, Andrzej Jakubowiak, Yi Lin, Sundar Jagannath - Journal of Clinical Oncology 2022 cited by 633

  3. Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

    Authors: Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, Ajay K. Nooka, Andrew J. Yee, Carol Ann Huff, Philippe Moreau, David Dingli, Craig E. Cole, Sagar Lonial, Meletios Α. Dimopoulos, A. Keith Stewart, Joshua Richter, Ravi Vij, Sascha A. Tuchman, Marc S. Raab, Katja Weisel, Michel Delforge, Robert F. Cornell, David Kaminetzky, James E. Hoffman, Luciano J. Costa, Terri L. Parker, Moshe Levy, Martin Schreder, Nathalie Meuleman, Laurent Frenzel, Mohamad Mohty, Sylvain Choquet, Gary J. Schiller, Raymond L. Comenzo, Monika Engelhardt, Thomas Illmer, Philip Vlummens, Chantal Doyen, Thierry Façon, Lionel Karlin, Aurore Perrot, Klaus Podar, Michael Kauffman, Sharon Shacham, Lingling Li, Shijie Tang, Carla Picklesimer, Jean‐Richard Saint‐Martin, Marsha Crochiere, Hua Chang, Samir Parekh, Yosef Landesman, Jatin J. Shah, Paul G. Richardson, Sundar Jagannath - New England Journal of Medicine 2019 cited by 673

  4. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

    Authors: Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, Cody Ashby, Michael Bauer, Faith E. Davies, Adam Rosenthal, Hongwei Wang, Pingping Qu, Antje Hoering, Mehmet Samur, Fadi Towfic, María Ortiz, Erin Flynt, Zhinuan Yu, Zhihong Yang, Dan Rozelle, John C. Obenauer, Matthew Trotter, Daniel Auclair, Jonathan J. Keats, Niccolò Bolli, Mariateresa Fulciniti, Raphaël Szalat, Philippe Moreau, Brian G.M. Durie, A. Keith Stewart, Hartmut Goldschmidt, Marc S. Raab, Hermann Einsele, Pieter Sonneveld, Jesús F. San Miguel, Sagar Lonial, Graham Jackson, Kenneth C. Anderson, Hervé Avet‐Loiseau, Nikhil Munshi, Anjan Thakurta, Gareth J. Morgan - Leukemia 2018 cited by 453

  5. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

    Authors: Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, Cody Ashby, Michael Bauer, Faith E. Davies, Adam Rosenthal, Hongwei Wang, Pingping Qu, Antje Hoering, Mehmet Samur, Fadi Towfic, María Ortiz, Erin Flynt, Zhinuan Yu, Zhihong Yang, Dan Rozelle, John C. Obenauer, Matthew Trotter, Daniel Auclair, Jonathan J. Keats, Niccolò Bolli, Mariateresa Fulciniti, Raphaël Szalat, Philippe Moreau, Brian G.M. Durie, A. Keith Stewart, Hartmut Goldschmidt, Marc S. Raab, Hermann Einsele, Pieter Sonneveld, Jesús F. San Miguel, Sagar Lonial, Graham Jackson, Kenneth C. Anderson, Hervé Avet‐Loiseau, Nikhil Munshi, Anjan Thakurta, Gareth J. Morgan - Blood 2018 cited by 495

  6. Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

    Authors: Jens G. Lohr, Petar Stojanov, Scott L. Carter, Peter Cruz‐Gordillo, Michael S. Lawrence, Daniel Auclair, Carrie Sougnez, Birgit Knoechel, Joshua Gould, Gordon Saksena, Kristian Cibulskis, Aaron McKenna, Michael A. Chapman, Ravid Straussman, Joan Levy, Louise M. Perkins, Jonathan J. Keats, Steven E. Schumacher, Mara Rosenberg, Gad Getz, Todd R. Golub, Kenneth C. Anderson, Paul G. Richardson, Amrita Krishnan, Sagar Lonial, Jonathan L. Kaufman, David S. Siegel, D. H. Vesole, Vivek Roy, Candido E. Rivera, S. Vincent Rajkumar, Shaji Kumar, Rafaël Fonseca, Greg Ahmann, P. Leif Bergsagel, A. Keith Stewart, Craig C. Hofmeister, Yvonne A. Efebera, Sundar Jagannath, Ajai Chari, Suzanne Trudel, Donna Reece, Jeffrey Wolf, Thomas Martin, Todd M. Zimmerman, Cara A. Rosenbaum, Andrzej Jakubowiak, Daniel Lebovic, Ravi Vij, Keith Stockerl-Goldstein - Cancer Cell 2014 cited by 1,004

  7. Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma

    Authors: A. Keith Stewart, S. Vincent Rajkumar, Meletios Α. Dimopoulos, Tamás Masszi, Ivan Špıčka, Albert Oriol, Roman Hájek, Laura Rosiñol, David S. Siegel, Georgi Mihaylov, Vesselina Goranova‐Marinova, Péter Rajnics, Aleksandr Suvorov, Rubén Niesvizky, Andrzej Jakubowiak, Jesús F. San Miguel, Heinz Ludwig, Michael Wang, Vladimír Maisnar, Jiří Minařík, William Bensinger, María-Victoria Mateos, Dina Ben‐Yehuda, Vishal Kukreti, Naseem J. Zojwalla, Margaret Tonda, Xinqun Yang, Biao Xing, Philippe Moreau, Antonio Palumbo - New England Journal of Medicine 2014 cited by 1,324

  8. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

    Authors: Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos, Alessandra Larocca, Thierry Façon, Shaji Kumar, Massimo Offidani, Philip L. McCarthy, Andrea Evangelista, Sagar Lonial, Sonja Zweegman, Pellegrino Musto, Evangelos Terpos, Andrew Belch, Roman Hájek, Heinz Ludwig, A. Keith Stewart, Philippe Moreau, Kenneth C. Anderson, Hermann Einsele, Brian G.M. Durie, Meletios Α. Dimopoulos, Ola Landgren, Jesús F. San Miguel, Paul G. Richardson, Pieter Sonneveld, S. Vincent Rajkumar - Blood 2015 cited by 762

  9. Initial genome sequencing and analysis of multiple myeloma

    Authors: Michael A. Chapman, Michael S. Lawrence, Jonathan J. Keats, Kristian Cibulskis, Carrie Sougnez, Anna C. Schinzel, Christina L. Harview, Jean-Philippe Brunet, Gregory Ahmann, Mazhar Adli, Kenneth C. Anderson, Kristin Ardlie, Daniel Auclair, Angela Baker, P. Leif Bergsagel, B Bernstein, Yotam Drier, Rafaël Fonseca, Stacey Gabriel, Craig C. Hofmeister, Sundar Jagannath, Andrzej Jakubowiak, Amrita Krishnan, Joan Levy, Ted Liefeld, Sagar Lonial, Scott Mahan, Bunmi Mfuko, Stefano Monti, Louise M. Perkins, Robb Onofrio, Trevor J. Pugh, S. Vincent Rajkumar, Alex H. Ramos, David S. Siegel, Andrey Sivachenko, A. Keith Stewart, Suzanne Trudel, Ravi Vij, Douglas Voet, Wendy Winckler, Todd M. Zimmerman, John D. Carpten, J.M. Trent, William C. Hahn, Levi A. Garraway, Matthew Meyerson, Eric S. Lander, Gad Getz, Todd R. Golub - Nature 2011 cited by 1,455

  10. Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome

    Authors: N. Jewel Samadder, Douglas L. Riegert‐Johnson, Lisa Boardman, Deborah J. Rhodes, Myra Wick, Scott H. Okuno, Katie L. Kunze, Michael A. Golafshar, Pedro Luiz Serrano Usón, Luke Mountjoy, Natalie Ertz-Archambault, Neej J. Patel, Eduardo A. Rodríguez, Blanca Lizaola‐Mayo, Michael Lehrer, C.S. Thorpe, Nathan Y. Yu, Edward D. Esplin, Robert L. Nussbaum, Richard R. Sharp, Cindy Azevedo, Margaret Klint, Megan M. Hager, Sarah K. Macklin‐Mantia, Alan H. Bryce, Tanios Bekaii‐Saab, Aleksandar Sekulić, A. Keith Stewart - JAMA Oncology 2020 cited by 294

  11. Genome-wide detection of tandem DNA repeats that are expanded in autism

    Authors: Brett Trost, Worrawat Engchuan, Charlotte Nguyen, Bhooma Thiruvahindrapuram, Egor Dolzhenko, Ian Backstrom, Mila Mirceta, Bahareh A. Mojarad, Yue Yin, Alona Dov, Induja Chandrakumar, Tanya Prasolava, Natalie Shum, Omar Hamdan, Giovanna Pellecchia, Jennifer Howe, Joseph Whitney, Eric W. Klee, Saurabh Baheti, David G. Amaral, Evdokia Anagnostou, Mayada Elsabbagh, Bridget A. Fernandez, Ny Hoang, M. E. Suzanne Lewis, Xudong Liu, Calvin Sjaarda, Isabel M. Smith, Péter Szatmári, Lonnie Zwaigenbaum, David Glazer, Dean M. Hartley, A. Keith Stewart, Michael A. Eberle, Nozomu Sato, Christopher E. Pearson, Stephen W. Scherer, Ryan K. C. Yuen - Nature 2020 cited by 260

  12. Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes

    Authors: K. Martin Kortüm, Elias K. Mai, Nur Hafzan Md Hanafiah, Chang-Xi Shi, Yuan-Xiao Zhu, Laura A. Bruins, Santiago Barrio, Patrick Jedlowski, Maximilian Merz, Jing Xu, Robert A. Stewart, Mindaugas Andrulis, Anna Jauch, Jens Hillengaß, Hartmut Goldschmidt, P. Leif Bergsagel, Esteban Braggio, A. Keith Stewart, Marc S. Raab - Blood 2016 cited by 256

  13. MYC dysregulation in the progression of multiple myeloma

    Authors: MMRF CoMMpass Network, Kristine Misund, Niamh Keane, Caleb K. Stein, Yan W. Asmann, Grady Day, Seth J. Welsh, Scott A. Van Wier, Daniel L. Riggs, Greg Ahmann, Marta Chesi, David S. Viswanatha, Shaji Kumar, Angela Dispenzieri, Verónica González‐Calle, Robert A. Kyle, Michael O’Dwyer, S. Vincent Rajkumar, K. Martin Kortüm, Jonathan J. Keats, Rafaël Fonseca, A. Keith Stewart, W. Michael Kuehl, Esteban Braggio, P. Leif Bergsagel - Leukemia 2019 cited by 159

  14. AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies

    Authors: Marta Chesi, Davide F. Robbiani, Michaël Sébag, Wee Joo Chng, Maurizio Affer, Rodger E. Tiedemann, Riccardo Valdez, Stephen Palmer, Stephanie S. Haas, A. Keith Stewart, Rafaël Fonseca, Richard Kremer, Giorgio Cattoretti, P. Leif Bergsagel - Cancer Cell 2008 cited by 383

  15. Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

    Authors: Jonathan J. Keats, Rafaël Fonseca, Marta Chesi, Roelandt F.J. Schop, Angela Baker, Wee Joo Chng, Scott Van Wier, Rodger E. Tiedemann, Chang-Xin Shi, Michaël Sébag, Esteban Braggio, Travis Henry, Yuan-Xiao Zhu, Homer Fogle, Tammy Price-Troska, Gregory Ahmann, Catherine Mancini, Leslie A. Brents, Shaji Kumar, Philip R. Greipp, Angela Dispenzieri, Barbara M. Bryant, George Mulligan, Laurakay Bruhn, Michael T. Barrett, Riccardo Valdez, J.M. Trent, A. Keith Stewart, John D. Carpten, P. Leif Bergsagel - Cancer Cell 2007 cited by 988

  16. Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma

    Authors: Hang Quach, David Ritchie, A. Keith Stewart, Paul J. Neeson, Simon J. Harrison, Mark J. Smyth, H. Miles Prince - Leukemia 2009 cited by 588

  17. Clonal competition with alternating dominance in multiple myeloma

    Authors: Jonathan J. Keats, Marta Chesi, Jan B. Egan, Victoria M. Garbitt, Stephen Palmer, Esteban Braggio, Scott Van Wier, Patrick R. Blackburn, Angela Baker, Angela Dispenzieri, Shaji Kumar, S. Vincent Rajkumar, John D. Carpten, Michael T. Barrett, Rafaël Fonseca, A. Keith Stewart, P. Leif Bergsagel - Blood 2012 cited by 636

  18. Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide

    Authors: Yuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi, Laura A. Bruins, Jessica Schmidt, Scott Van Wier, Xiu-Bao Chang, Chad C. Bjorklund, Rafaël Fonseca, P. Leif Bergsagel, Robert Z. Orlowski, A. Keith Stewart - Blood 2011 cited by 602

  19. Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma

    Authors: Yuan Xiao Zhu, K. Martin Kortuem, A. Keith Stewart - Leukemia & lymphoma/Leukemia and lymphoma 2012 cited by 288

  20. Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

    Authors: Shaji Kumar, Betsy LaPlant, Wee Joo Chng, Jeffrey A. Zonder, Natalie S. Callander, Rafaël Fonseca, Briant Fruth, Vivek Roy, Charles Erlichman, A. Keith Stewart - Blood 2014 cited by 255

  21. IAP antagonists induce anti-tumor immunity in multiple myeloma

    Authors: Marta Chesi, Noweeda Mirza, Victoria M. Garbitt, Meaghen E. Sharik, Amylou C. Dueck, Yan W. Asmann, Ilseyar Akhmetzyanova, Heidi Kosiorek, Arianna Calcinotto, Daniel L. Riggs, Niamh Keane, Gregory Ahmann, Kevin M. Morrison, Rafaël Fonseca, Martha Q. Lacy, David Dingli, Shaji Kumar, Sikander Ailawadhi, Angela Dispenzieri, Francis K. Buadi, Morie A. Gertz, Craig B. Reeder, Yi Lin, Asher Chanan‐Khan, A. Keith Stewart, David Fooksman, P. Leif Bergsagel - Nature Medicine 2016 cited by 171

  22. Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy

    Authors: Marta Chesi, Geoffrey M. Matthews, Victoria M. Garbitt, Stephen Palmer, Jake Shortt, Marcus Lefebure, A. Keith Stewart, Ricky W. Johnstone, P. Leif Bergsagel - Blood 2012 cited by 209

  23. Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

    Authors: A. Keith Stewart, Amrita Krishnan, Seema Singhal, Ralph V. Boccia, Manish R. Patel, Rubén Niesvizky, Asher Chanan‐Khan, Sikander Ailawadhi, Jochen Brumm, Kirsten Mundt, Kyu Hong, Jacqueline McBride, Quyen Shon-Nguyen, Yuanyuan Xiao, Vanitha Ramakrishnan, Andrew G. Polson, Divya Samineni, Douglas D. Leipold, Eric W. Humke, James Scott McClellan, Jesús G. Berdeja - Blood Cancer Journal 2019 cited by 59

  24. Carfilzomib

    Authors: K. Martin Kortuem, A. Keith Stewart - Blood 2013 cited by 199